Northern Trust Corp Roivant Sciences Ltd. Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Northern Trust Corp holds 3,448,082 shares of ROIV stock, worth $37 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,448,082
Previous 2,795,467
23.35%
Holding current value
$37 Million
Previous $32.3 Million
26.45%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding ROIV
# of Institutions
329Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$705 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$665 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$513 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$473 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$379 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.55B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...